Minor
Obinutuzumab, Venetoclax, and Lenalidomide · Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Primary completion date changed from estimate of Aug 15, 2026 to Apr 22, 2020
Also in this update: Study completion pushed from Aug 15, 2026 to Apr 15, 2027
Beth ChristianPhase 1 NCT02992522 Registry history of NCT02992522 on ClinicalTrials.gov (opens the registry)